A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M. Gelfand, Daniel B. Shin, Kristina Callis Duffin, April Armstrong, Andrew Blauvelt, Stephen K. Tyring, Alan Menter, Scott Gottlieb, Benjamin Lockshin, Eric L. Simpson, Farid Kianifard, R. Sarkar, Elisa Muscianisi, Jennifer Steadman, Mark A. Ahlman, Martin P. Playford, Aditya A. Joshi, Amit K. Dey, Thomas Werner, Abass Alavi, Nehal N. Mehta
Topics & Concepts
SecukinumabMedicinePsoriasisPlaceboInflammationRandomized controlled trialPlaque psoriasisDermatologyInternal medicineDiseasePsoriatic arthritisPathologyAlternative medicinePsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsInflammatory Bowel Disease